Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study

被引：0
|
作者：
Goebel, C. [1 ,2 ]
Heinze, A. [2 ]
Karstedt, S. [1 ,2 ]
Morscheck, M. [2 ]
Tashiro, L. [2 ]
Cirkel, A. [1 ,2 ]
Hamid, Q. [3 ]
Halwani, R. [3 ]
Temsah, M. H. [4 ]
Ziemann, M. [5 ]
Goerg, S. [5 ]
Muente, T. [1 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany
[2] Kiel Headache & Pain Ctr, Kiel, Germany
[3] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates
[4] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[5] Univ Hosp Schleswig Holstein, Inst Transfus Med, Lubeck, Germany
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P041
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [11] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Goebel, Carl H.
    Heinze, Axel
    Karstedt, Sarah
    Morscheck, Mascha
    Tashiro, Lilian
    Cirkel, Anna
    Hamid, Qutyaba
    Halwani, Rabih
    Temsah, Mohamad-Hani
    Ziemann, Malte
    Goerg, Siegfried
    Muente, Thomas
    Goebel, Hartmut
    PAIN AND THERAPY, 2021, 10 (02) : 1309 - 1330
  • [12] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Carl H. Göbel
    Axel Heinze
    Sarah Karstedt
    Mascha Morscheck
    Lilian Tashiro
    Anna Cirkel
    Qutyaba Hamid
    Rabih Halwani
    Mohamad-Hani Temsah
    Malte Ziemann
    Siegfried Görg
    Thomas Münte
    Hartmut Göbel
    Pain and Therapy, 2021, 10 : 1309 - 1330
  • [13] Migraine and COVID-19: Migraine headache developement after COVID-19 and SARS-CoV-2 vaccination in migraine patients
    Blazkova, K.
    Markova, J.
    Klecka, L.
    Niedermayerova, I.
    Rehulka, P.
    Kotas, R.
    Ctrnacta, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 375 - 375
  • [14] Analysis of SARS-CoV-2 vaccine against COVID-19
    Kazuyori, Taisuke
    Sato, Akihito
    Morimoto, Yasuhiro
    Ito, Akihiko
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2023, 28 : 202 - 203
  • [15] Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
    Krsak, Martin
    Harry, Brian L.
    Palmer, Brent E.
    Franco-Paredes, Carlos
    VIRAL IMMUNOLOGY, 2021, 34 (08) : 504 - 509
  • [16] Vaccine against COVID-19 or against SARS-CoV-2 infection?
    Rieske, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (03) : 131 - 145
  • [17] SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
    Giacomelli, Andrea
    Righini, Elena
    Micheli, Valeria
    Pinoli, Pietro
    Bernasconi, Anna
    Rizzo, Alberto
    Oreni, Letizia
    Ridolfo, Anna Lisa
    Antinori, Spinello
    Ceri, Stefano
    Rizzardini, Giuliano
    PLOS ONE, 2023, 18 (04):
  • [18] SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study
    Nersesjan, Vardan
    Amiri, Moshgan
    Nilsson, Anna Christine
    Wamberg, Christian
    Jensen, Veronika Vorobieva Solholm
    Petersen, Charlotte Bjerg
    Hejl, Anne-Mette
    Lebech, Anne-Mette
    Theut, Anna Marie
    Jorgensen, Charlotte Svaerke
    Blaabjerg, Morten
    Benros, Michael E.
    Kondziella, Daniel
    BRAIN COMMUNICATIONS, 2023, 5 (05)
  • [19] Characteristics of SARS-CoV-2 and COVID-19
    Ben Hu
    Hua Guo
    Peng Zhou
    Zheng-Li Shi
    Nature Reviews Microbiology, 2021, 19 : 141 - 154
  • [20] Characteristics of SARS-CoV-2 and COVID-19
    Hu, Ben
    Guo, Hua
    Zhou, Peng
    Shi, Zheng-Li
    NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 141 - 154
12345